| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.07 |